Legal & General Group PLC Durect Corp Transaction History

Legal & General Group PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.43 - $5.9 $7,501 - $102,925	-17,445 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$0.38 - $0.64 $2,230 - $3,757	-5,871 Reduced 25.18%	17,445 $8,000
Q4 2021 Feb 14, 2022	SELL	$0.9 - $1.31 $46,827 - $68,159	-52,030 Reduced 69.05%	23,316 $23,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.61 $52,822 - $70,284	43,655 Added 137.75%	75,346 $97,000
Q2 2021 Aug 12, 2021	SELL	$1.6 - $2.02 $4,120 - $5,201	-2,575 Reduced 7.51%	31,691 $52,000
Q1 2021 May 17, 2021	BUY	$1.86 - $2.87 $2,845 - $4,391	1,530 Added 4.67%	34,266 $68,000
Q3 2020 Nov 13, 2020	SELL	$1.6 - $2.35 $13,275 - $19,497	-8,297 Reduced 20.22%	32,736 $56,000
Q2 2020 Aug 14, 2020	BUY	$1.33 - $2.76 $54,573 - $113,251	41,033 New	41,033 $95,000
Q3 2019 Nov 13, 2019	SELL	$0.61 - $2.21 $14,401 - $52,175	-23,609 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$1.56 - $2.51 $6,048 - $9,731	-3,877 Reduced 14.11%	23,609 $37,000
Q1 2018 May 17, 2018	BUY	$0.91 - $2.24 $1,851 - $4,558	2,035 Added 8.0%	27,486 $59,000
Q4 2017 Feb 13, 2018	BUY	$0.78 - $2.1 $19,851 - $53,447	25,451	25,451 $24,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $230M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.